News

Pfizer-BioNTech asks FDA to authorize omicron booster for children under 5

By Abigail Adcox
Published December 5, 2022 3:28pm ET
Add Washington Examiner on Google
Pfizer-BioNTech asks FDA to authorize omicron booster for children under 5
Pfizer and BioNTech have asked the Food and Drug Administration for emergency use authorization of their COVID-19 booster targeting omicron subvariants BA.4 and BA.5 and the original strain of the virus from 2020 for children 6 months through 4 years. Children within that age group would receive the omicron boosters as the third shot in […]

Pfizer and BioNTech have asked the Food and Drug Administration for emergency use authorization of their COVID-19 booster targeting omicron subvariants BA.4 and BA.5 and the original strain of the virus from 2020 for children 6 months through 4 years.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

Children COVID-19 FDA Vaccines